Silver(I) complexes of 9-anthracenecarboxylic acid and imidazoles: synthesis,

structure and antimicrobial activity by McCann, Malachy et al.
Dalton
Transactions
Dynamic Article Links
Cite this: Dalton Trans., 2012, 41, 6516
www.rsc.org/dalton PAPER
Silver(I) complexes of 9-anthracenecarboxylic acid and imidazoles: synthesis,
structure and antimicrobial activity†
Malachy McCann,a Robert Curran,a Marcia Ben-Shoshan,a Vickie McKee,*b Asif Ali Tahir,b
Michael Devereux,c Kevin Kavanagh,d Bernadette S. Creavene and Andrew Kellettf
Received 12th November 2011, Accepted 16th March 2012
DOI: 10.1039/c2dt12166b
[Ag2(9-aca)2] (1) (9-acaH = 9-anthracenecarboxylic acid) reacts with a series of imidazoles to give
[Ag(imidH)2.3(CH3CN)0.7](9-aca) (3), [Ag6(imidH)4(9-aca)6(MeOH)2] (4), {[Ag(1-Me-imid)2]2[Ag4(9-
aca)6]} (5), {[Ag(1-Bu-imid)2]2[Ag4(9-aca)6]} (6) and [Ag(apim)](9-aca)·H2O (7) (imidH = imidazole;
1-Me-imid = 1-methylimidazole; 1-Bu-imid = 1-butylimidazole; apim = 1-(3-aminopropyl)imidazole).
The mononuclear complex 3, hexanuclear 4–6, and polymeric 7, were all characterised using X-ray
crystallography. While many of the complexes possess excellent in vitro antifungal and antibacterial
activities they are, unanimously, more effective against fungal cells. The insect, Galleria mellonella, can
survive high doses of the Ag(I) complexes administered in vivo, and a number of the complexes offer
significant protection to larvae infected with a lethal dose of pathogenic Candida albicans cells.
Introduction
Pathogenic fungi and bacteria cause many infectious diseases in
both immunosuppressed and immunocompetent individuals.
Additionally, infections with resistant microorganisms are often
associated with high rates of morbidity and mortality and also
increase health care treatment costs.1–4 In recent times, there has
been something of a renaissance in the use of nanoparticulate
silver(0) and silver(I) complexes to prevent and to treat stubborn
microbial infections. Despite the fact that microbial resistance to
Ag(I) is relatively rare, Ag(I)-resistance genes have been ident-
ified, giving rise to concerns over the widespread use of clinical
and hygiene products containing silver.5 Although a small
number of people experience delayed sensitivity to silver, the
metal and its monocation do not present a serious toxic risk to
any organ system in the human body.6
The Ag(I) ion is now the active agent in many healthcare pro-
ducts such as silver-coated catheters,7 wound dressings8,9 and
burn treatment creams.10 Evidence has been provided11 for the
antifungal activity of a burn wound dressing coated with AgNO3
against Candida albicans, C. glabrata, C. tropicalis and Sac-
charomyces cerevisiae. Ag(0) nanoparticles have been incorpor-
ated into a topical antimicrobial gel and demonstrated potent
activity against Aspergillus niger and C. albicans.12 The anti-
microbial effects of medical devices containing Ag(0) have
formed the basis of a recent review which highlights the growing
importance of materials that prevent microbial surface
adhesion.13
The Ag(I) ion is known to interfere with electron transport14
and alter the respiration of C. albicans cells.15 McCann and co-
workers suggested that the interaction of Ag(I) and the
mitochondrion,14–16 coupled with the generation of lipid per-
oxides,14 was evidence for the generation of free radicals. More
recently,17 it has been demonstrated that C. albicans cells
respond to AgClO4 by activating an oxidative stress response via
phosphorylation of a high osmolarity protein (Hog1P) and
nuclear translocation of the C. albicans activating protein-1
(Cap1p). The high antimicrobial efficacy of tetrahedral, Ag(I)
bis-phosphine18 and N-heterocyclic carbene19 complexes has
been demonstrated. Li and coworkers20 reported that the hexa-
nuclear Ag(I) complex, [Ag6L6]·4DMF (HL = 2-thiophene N(4)-
methylthiosemicarbazone), showed moderate activity against
Gram negative and Gram positive bacteria with MIC100 values
(minimum inhibitory concentration of complex required for
100% retardation of bacterial cell growth) ≥0.5 μg cm−3 and dis-
played poor growth inhibition towards the fungi, C. albicans and
C. lusitaniae. In recent studies, [Ag2(phen)3(mal)]·2H2O (phen
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= 1,10-phenanthroline; malH2 = malonic acid) was shown to
inhibit the growth of C. albicans, by affecting mitochondrial
function, retarding cytochrome synthesis, uncoupling cellular
respiration and causing gross distortions in cell morphology.21
The mononuclear complex, [Ag(phendio)2]ClO4 (phendio =
1,10-phenanthroline-5,6-dione), strongly inhibited the growth of
C. albicans and caused extensive, non-specific DNA cleavage in
the organism.22 Against the same fungi, the Ag(I) salicylate com-
plexes, [Ag2(salH)2] and [Ag2(NH3)2(salH)2] (salH2 = salicylic
acid), had MIC100 values of 5.0 and 0.5 μM, respectively.
23
Investigations into the effects of silver(I) ions on bacterial
cells revealed that they interact with the respiratory chain of
Escherichia coli24 and can lower the content of phospholipid
fatty acids in some metal-reducing bacteria.25 Electron
microscopy and X-ray microanalysis have shown that silver
builds up as granules in the cell wall and in the cytoplasm of
E. coli and Staphylococcus aureus,26,27 inflicting damage to the
RNA and DNA and also deactivating cellular proteins. The most
widely known bactericidal mechanism of the Ag(I) ion is its
interaction with the thiol group of the L-cysteine residue of pro-
teins and consequent enzyme inactivation.28–30 Other Ag(I) bac-
tericidal mechanisms, such as K+ ion release,31 bonding to
DNA32 and the generation of intracellular reactive oxygen
species,24,33,34 have also been reported.
In 2007, we reported35 the structures and biological activities
of dinuclear and tetranuclear Ag(I) complexes containing the 9-
anthracenecarboxylate anion (9-acaH = 9-anthracenecarboxylic
acid (Fig. 1)). [Ag2(9-aca)2] (1) was found to be very active
against the bacterial species E. coli and methicillin-resistant
S. aureus (MRSA) (MIC50 = 22.44 and 11.36 μM, respectively)
and against the fungus C. albicans (MIC100 = 0.95 μM).
However, the tetranuclear, amine complex, [Ag4(9-aca)4(NH3)2]
(2), displayed enhanced activity universally against the microbial
cells (corresponding inhibitory concentrations were 8.51, 5.44
and 0.14 μM, respectively).35 The significant improvement in
biological activity witnessed upon the introduction of the NH3
ligands in 2 and in [Ag2(NH3)2(salH)2]
23 was the stimulus for
the present work.
Herein, we report the synthesis, structures and in vitro antimi-
crobial effects of a series of new Ag(I) complexes containing
both the 9-aca− anion and N-donor ligands based on imidazole
(Fig. 1). Metal complexes containing imidazole-based ligands
are also of interest because the imidazole ring is an essential
metal binding site in many metalloproteins. In addition to
measuring the in vitro antimicrobial properties of the present
Ag(I) complexes their in vivo cytotoxicities were also examined
using the insect model, Galleria mellonella.
Experimental
Infrared spectra were recorded in the region 4000–370 cm−1 on a
Perkin Elmer System 2000 FT spectrometer. Microanalytical
data were provided by the Microanalytical Laboratory, University
College Dublin, Belfield, Dublin 4, Ireland. X-ray crystallo-
graphic data (Table 1) were collected at 150(2) K on a Bruker
APEX II diffractometer and the structures were solved by direct
methods and refined on F2 using all the reflections.36 All of
the non-hydrogen atoms were refined using anisotropic atomic
displacement parameters. Hydrogen atoms were inserted atFig. 1 Ligand structures.
Table 1 Crystallographic data for complexes 3–7
Complex 3 4 5 6 7
Formula C23.30H20.3Ag N5.3O2 C104H78Ag6N8O14 C106H78Ag6N8O12 C118H102Ag6N8O12 C21H22AgN3O3
Formula weight 514.42 2310.96 2302.98 2471.30 472.29
Crystal size, mm3 0.33 × 0.22 × 0.21 0.23 × 0.15 × 0.12 0.43 × 0.32 × 0.06 0.32 × 0.19 × 0.12 0.20 × 0.17 × 0.07
Crystal system Monoclinic Orthorhombic Triclinic Triclinic Orthorhombic
Space group P21/n Pbcn P1ˉ P1ˉ Pbca
a, Å 9.7905(5) 20.6935(8) 11.7251(17) 17.6333(7) 9.6450(6)
b, Å 14.2012(7) 18.2786(7) 17.908(3) 19.3853(8) 19.0589(11)
c, Å 16.3251(9) 23.6859(10) 23.464(3) 30.4753(13) 21.2920(12)
α, ° 90 90 111.403(2) 96.019(1) 90
β, ° 101.864(1) 90 90.095(2) 95.831(1) 90
γ, ° 90 90 101.710(2) 90.237(1) 90
V, Å3 2221.3(2) 8959.1(6) 4476.2(11) 10 305.1(7) 3914.0(4)
Z 4 4 2 4 8
Dc, Mg m
−3 1.538 1.713 1.709 1.593 1.603
μ, mm−1 0.938 1.358 1.357 1.185 1.057
Refl collected 19 005 80 667 35 083 89 958 37 907
Refl unique (Rint) 4361 (0.0326) 9793 (0.0580) 15 686(0.0421) 40 407(0.0422) 4890 (0.0398)
Data/restraints/parameters 4361/23/326 9793/0/599 15 686/0/1194 40 407/ 3021/2665 4890/6/265
Goodness-of-fit on F2 1.049 1.025 1.049 1.067 1.027
R1, wR2 [I > 2σ(I)] 0.0347, 0.0730 0.0316, 0.0695 0.0666, 0.1746 0.0505, 0.1130 0.0280, 0.0665
R1, wR2 (all data) 0.0460, 0.0782 0.0475, 0.0765 0.0856 0.1882 0.0739, 0.1228 0.0410, 0.0723
Δρmin, Δρmax, e Å
−3 0.936, −1.192 0.487, −0.788 4.988, −1.066 1.703, −0.978 0.447, −0.546
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 6516–6527 | 6517
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calculated positions using a riding model, except for those
bonded to oxygen or nitrogen in complex 7, which were located
from difference maps and the coordinates refined. When the
refinement for complex 5 had converged there remained a
number of peaks in the electron density map at ca. 5 e Å−3, and
a second crystal showed the same effect. The geometry of these
peaks was similar to the arrangement of silver ions in the main
components, and it seems likely that these effects are due to a
small twin contribution. However, attempts to incorporate this
did not improve the model. In complex 6 there are two indepen-
dent {[Ag(1-Bu-imid)2]2[Ag4(9-aca)6]} assemblies in the asym-
metric unit, oriented about 90° to each other and very similar to
one another. There is a disorder in the alkyl substituents attached
to four of the eight imidazole groups and these were each mod-
elled with partial occupancy of two overlapping sites (50 : 50 or
60 : 40). Some restraints (SAME and ISOR) were also employed.
Sterilisation of microbiological equipment and media was
carried out at 394 K and 124 kPa for 20 min. Solutions that were
susceptible to decomposition during autoclaving were sterilised
by membrane filtration using 0.45 μm Millipore membrane
filters. All worktops and benches were sterilised by washing
with 70% (v/v) ethanol–water prior to use. Round-bottomed
microtitre plates were read using a Labsystems iEMS Reader MF
at 540 nm (C. albicans). Flat-bottomed microtitre plates were
read using a Bio-Tek Synergy HT plate reader at 600 nm (E. coli
and MRSA). Fungal cell density was measured using a Neu-
bauer hemocytometer under a light microscope at a magnifi-
cation of ×400. Bacterial cell density was recorded at an optical
density of 600 nm using an Eppendorf Biophotometer.
Chemicals were purchased from commercial sources and were
used without further purification. All of the silver(I) complexes
were synthesised in the absence of light and the products were
stored in the dark. [Ag4(9-aca)4(NH3)2] (2) was prepared from
[Ag2(9-aca)2] (1) in accordance with the literature method.
35
C. albicans ATCC 10231 was obtained from the American Type
Culture Collection, Manassas, VA, USA. E. coli was supplied as
a clinical isolate by the Clinical Microbiology Laboratory,
St. James’s Hospital, Dublin, Ireland, and was originally isolated
from a wound infection. MRSAwas obtained as a clinical isolate
from Microbiologics, North St. Cloud Mn, USA, and was orig-
inally isolated from a wound infection. G. mellonella larvae in
the sixth developmental stage were obtained from Livefoods
Direct Ltd., Sheffield, S25 4JJ, UK. They were stored at 288 K
in wood shavings and used within 3 weeks of delivery. Signifi-
cance of the larvae survival rates was analysed at 72 h using
the log rank (Mantel–Cox) method utilising GraphPad Prism
software (version 5). Three categories of significance were used
(* = p < 0.05, ** = p < 0.01 and *** = p < 0.001).
Preparation of [Ag2(9-aca)2] (1)
This complex was prepared using an improved modification of
the literature procedure.35 9-Anthracenecarboxylic acid (9-acaH)
(1.117 g, 5.03 mmol) was added slowly to a solution of potass-
ium hydroxide (0.282 g, 5.03 mmol) in water (30 cm3) until
pH 7 was reached. The solution was then filtered to remove any
undissolved material. A solution of silver nitrate (0.849 g,
5.03 mmol) in water (10 cm3) was added dropwise to the
K+(9-aca)− solution. The resulting suspension was stirred for
0.5 h and then filtered. The yellow solid was washed with
ethanol and air-dried. Yield: 1.202 g (73%).
Preparation of crystalline [Ag(imidH)2.3(CH3CN)0.7](9-aca) (3)
[Ag2(9-aca)2] (1) (0.329 g, 0.5 mmol) was stirred in hot aceto-
nitrile (70 cm3) and any small traces of undissolved material was
removed by filtration. Imidazole (0.207 g, 3.0 mmol) was dis-
solved in acetonitrile (10 cm3) and added slowly to the stirred
solution of 1. The small amount of white precipitate which
formed was filtered off and the clear filtrate was allowed to stand
overnight. The white crystalline product which formed was
filtered off, washed with acetonitrile and air-dried. Yield: 0.09 g
(18%). Solubility: soluble in MeOH, hot EtOH and DMSO.
Anal. calcd for C23.30H20.30AgN5.30O2: C, 54.40; H, 3.98;
N, 14.43%. Found: C, 54.15; H, 3.91; N, 14.61%. IR (cm−1,
KBr): 3436, 3128, 3030, 2923, 2837, 2700, 2624, 2250, 1625,
1562, 1448, 1426, 1390, 1320, 1275, 1261, 1072.
Preparation of crystalline [Ag6(imidH)4(9-aca)6(MeOH)2] (4)
[Ag2(9-aca)2] (1) (0.109 g, 0.16 mmol) was suspended in metha-
nol (10 cm3) and to this was added a methanolic solution of imi-
dazole (1 cm3, 0.16 M, 0.16 mmol). The mixture was stirred for
1 h and then filtered. Diethyl ether was slowly added to the
filtrate to precipitate the pale-yellow product. The solid was
filtered off, washed with diethyl ether and air-dried. Crystals of
the product formed in the ether filtrate. Yield: 0.04 g (44%).
Solubility: soluble in MeOH and DMSO. Anal. calcd for
C104H78Ag6N8O14: C, 54.05; H, 3.40; N, 4.85%. Found: C,
53.75; H, 3.39; N, 4.73%. IR (cm−1, KBr): 3448, 3045, 1625,
1538, 1484, 1433, 1393, 1320, 1273, 1238, 1178, 1090.
Preparation of crystalline {[Ag(1-Me-imid)2]2[Ag4(9-aca)6]} (5)
1-Methylimidazole (0.82 g, 1.0 mmol) was added to a hot sus-
pension of [Ag2(9-aca)2] (1) (0.165 g, 0.25 mmol) in ethanol
(30 cm3) and the mixture immediately turned clear. Following
filtration to remove any insoluble particles the filtrate was
reduced to low volume by rotary evaporation. Diethyl ether was
added to precipitate the beige solid, which was filtered off,
washed with diethyl ether and allowed to air-dry. The solid was
dissolved in DMSO and the solution reduced under high vacuum
to yield the beige product. The solid was washed with a small
amount of cold EtOH and air dried. The solid was again dis-
solved in the minimum volume of DMSO and crystals formed
when the solution was allowed to stand for one week. Yield:
0.075 g (37%). Solubility: soluble in hot MeOH, EtOH and
DMSO. Anal. calcd for C106H78Ag6N8O12: C, 55.27; H, 3.42;
N, 4.87%. Found: C, 54.98; H, 3.42; N, 4.63%. IR (cm−1, KBr):
3468, 3116, 1621, 1565, 1536, 1428, 1392, 1321, 1275, 1235,
1180, 1112, 1087, 1017.
Preparation of crystalline {[Ag(1-Bu-imid)2]2[Ag4(9-aca)6]} (6)
[Ag2(9-aca)2] (1) (0.750 g, 1.14 mmol) was dissolved in hot
acetonitrile (80 cm3) and the solution filtered to remove any
6518 | Dalton Trans., 2012, 41, 6516–6527 This journal is © The Royal Society of Chemistry 2012
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traces of undissolved solid. The filtrate was allowed to cool to
room temperature. 1-Butylimidazole (0.567 g, 4.56 mmol) was
added and the resulting solution was stirred at room temperature
for 20 h. After gravity filtration the filtrate was reduced to a low
volume on a rotary evaporator and then diethyl ether was slowly
added. The precipitated beige solid was filtered off, washed with
diethyl ether and allowed to air-dry. The solid was recrystallised
from hot ethanol to yield yellow crystals, which were then
filtered off, washed with cold ethanol (1 cm3) and allowed to air-
dry. Yield: 0.301 g (51%). Solubility: soluble in MeOH, hot
EtOH, CHCl3 and DMSO. Anal. calcd for C118H102Ag6N8O12:
C, 57.35; H, 4.16; N, 4.53%. Found: C, 57.23; H, 4.23; N,
4.47%. IR (cm−1, KBr): 3468, 2958, 1622, 1565, 1536, 1427,
1391, 1321, 1274, 1232, 1179, 1112, 1085, 1018.
Preparation of crystalline [Ag(apim)](9-aca)·H2O (7)
[Ag2(9-aca)2] (1) (0.500 g, 0.76 mmol) was dissolved in hot
acetonitrile (70 cm3) and the solution filtered to remove any
undissolved particles. 1-(3-Aminopropyl)imidazole (0.190 g,
1.52 mmol) was dissolved in acetonitrile (5 cm3) and added to
the stirred solution of 1. The resulting suspension was stirred for
0.5 h at room temperature and the beige solid was filtered off,
washed with acetonitrile and air-dried. The solid was recrystal-
lised from a 9 : 1 ethanol–methanol mixture to yield colourless
crystals. Yield: 0.589 g (82%). Solubility: soluble in MeOH, hot
EtOH and DMSO. Anal. calcd for C21H22AgN3O3: C, 53.40; H,
4.70%; N, 8.90%. Found: C, 53.31; H, 4.58%; N, 8.89%. IR
(cm−1, KBr): 3427, 3236, 3129, 3046, 2932, 1568, 1518, 1425,
1389, 1319, 1277, 1231, 1112, 1089, 1055.
In vitro antimicrobial screening. Minimal growth media
(MM) was prepared as previously described.35 Yeast extract
peptone dextrose (YEPD) media was composed of 2% (w/v)
glucose, 2% (w/v) bacteriological peptone and 1% (w/v) yeast
extract. To solidify the media 2% (w/v) bacteriological agar was
added when required. Nutrient broth and phosphate buffered
saline (PBS) were made up according to the manufacturer’s
instructions (Scharlau Microbiology and Aldrich, respectively).
In vitro bacterial susceptibility testing. E. coli and methicillin-
resistant S. aureus (MRSA) were grown on nutrient broth agar
plates at 310 K and maintained at 277 K for short-term storage.
All assays were run in triplicate and on three independent
occasions. Fresh solutions of complexes were prepared immedi-
ately prior to testing. Complexes (0.020 g) were added to DMSO
(1 cm3) then water (9 cm3) was added to give a stock solution
(concentration 2000 mg cm−3). Complexes with low solubility
were tested as fine suspensions. The stock solution (1 cm3) was
added to water (9 cm3) to yield a solution/suspension with a con-
centration of 200 μg cm−3.
Nutrient broth (100 μl) was added to each well of a 96-well,
flat-bottomed microtitre plate. Water (100 μl) was added to
column 1 of the plate (negative control with no bacterial cells).
Column 2 was the positive control (media with bacterial cells).
100 μl of the above complex solution (200 μg cm−3) was added
to every well in column 3. Serial dilutions (1 : 1) were made
from column 3–12 to produce a test concentration range of
100–0.2 μg cm−3.
E. coli and MRSA were grown overnight to the stationary
phase in nutrient broth at 310 K and 200 rpm. The cells were
diluted to give an optical density of 0.1 at λ = 600 nm. The cell
suspension (100 μl) was added to every well in columns 2–12.
The completed plates were incubated at 310 K in a static incuba-
tor and the final optical density recorded. MIC50 values
(minimum concentration required to inhibit 50% of cell growth)
were then determined and expressed in terms of μM
concentration.
In vitro fungal susceptibility testing. C. albicans (ATCC
10231) was grown on YEPD agar plates at 310 K and main-
tained at 277 K for short-term storage. All assays were run in tri-
plicate and on three independent occasions. Fresh solutions of
complexes were prepared immediately prior to testing. Com-
plexes (0.020 g) were dissolved in DMSO (1 cm3) and added to
water (9 cm3) to give a stock solution (concentration 2000 mg
cm−3). Complexes with low solubility were tested as fine suspen-
sions. The stock solution (or suspension) (0.5 cm3) was added to
water (9.5 cm3) to give a solution with a concentration of 100 μg
cm−3. MM (100 μl) was added to each well of a 96-well, round-
bottomed microtitre plate. Water (100 μl) was added to column 1
of the plate (negative control, media with no fungal cells).
Column 2 was the positive control (media and fungal cells only).
100 μl of the above complex solution (100 μg cm−3) was added
to every well in column 3. Serial dilutions (1 : 1) were made
from columns 3–12 to produce a test concentration range of
50–0.1 μg cm−3.
C. albicans was grown to the stationary phase overnight at
310 K on YEPD media. The cells were washed with PBS sol-
ution and resuspended in MM at a density of 5 × 105 cells cm−3.
The cell suspension (100 μl) was added to every well in
columns 2–12. The completed plate was then covered with
acetate foil (Sarstedt) to prevent dehydration. The plate was incu-
bated at 310 K with continuous shaking for 24 h. The optical
density (λ = 540 nm) of each well was recorded at 1 h intervals.
MIC100 values were then determined and expressed in terms of
μM concentration.
In vivo cytotoxicity studies using Galleria mellonella. Since
the immune system of insects bears a number of strong structural
and functional similarities to the innate immune system of
mammals,37,38 insects can be used to screen the in vivo effect of
drugs without the necessity of mammalian testing. The larvae of
the greater wax moth, G. mellonella, have been utilised success-
fully since 1982 for in vivo studies of the pathogenicity of bac-
teria and fungi.39–43 With specific reference to C. albicans, the
G. mellonella model has provided invaluable information from
fungal virulence studies.44–48 Furthermore, the curative effects of
antifungal prescription drugs49 and some silver(I) compounds50
on C. albicans-infected G. mellonella have already been
determined.
G. mellonella larvae in the sixth developmental stage were
used to determine the in vivo cytotoxicity of ketoconazole,
AgNO3 and complexes 1–7. Ten healthy larvae, between
0.20–0.40 g in weight and with no cuticle discoloration, were
used in each test. Fresh solutions of the test complexes were pre-
pared immediately prior to testing. Test compounds (0.020 g)
were dissolved in DMSO (1 cm3) and added to water (9 cm3) to
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 6516–6527 | 6519
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give a stock solution (concentration 2000 mg cm−3). Test sol-
utions were made from this stock solution. In cases of limited
solubility the resulting suspensions were used for the tests. Each
compound was tested at two concentrations; 100 μg cm−3 and
twice their MIC100 value (in μg cm
−3). The test solution (20 μl)
was administered to the larvae by injection directly into the hae-
mocoel through the last pro-leg. The base of the pro-leg can be
opened by applying gentle pressure to the sides of the larvae and
this aperture will re-seal after removal of the syringe without
leaving a scar. Larvae were placed in sterile petri dishes and
incubated at 303 K for 72 h. Larvae survival was monitored after
this 72 h period. Death was assessed by the lack of movement in
response to stimulus together with discoloration of the cuticle.
Three controls were employed in all assays. The first consisted
of untouched larvae maintained at the same temperature as the
test larvae. The second was larvae with the pro-leg pierced with
an inoculation needle but no substance injected into them. The
third control was larvae that were inoculated with 20 μl of the
same sterile water used to make the test solutions.
In vivo antifungal screening using G. mellonella. G. mello-
nella larvae in the sixth developmental stage were used to deter-
mine the in vivo antimicrobial activity of ketoconazole, AgNO3
and complexes 1–7. As with the cytotoxicity studies (see above)
ten larvae were injected with a fresh solution (or suspension) of
the complex. Test concentrations were again 100 μg cm−3 and
twice their MIC100 value (in μg cm
−3). C. albicans was grown to
the stationary phase in YEPD media at 310 K for 24 h. The cell
concentration was assessed using a haemocytometer following
dilution of the culture with PBS. The cells were washed three
times with PBS and re-suspended in sterile PBS following har-
vesting by centrifugation (4000 × g for 10 min) to yield a sus-
pension of 1 × 108 cell cm−3.
Two treatments (prophylactic and treatment of infection) were
employed in the screening of the test solutions. Five controls
were used in each assay. The first control consisted of untouched
larvae maintained at the same temperature as the test larvae
(negative control). The second was larvae with the pro-leg
pierced with an inoculation needle but no substance injected into
them. The third control was larvae that were inoculated with the
same sterile water (20 μl) used to make the test solutions, and
the fourth was larvae inoculated with the same sterile PBS sol-
ution used to wash and make the C. albicans suspension. The
positive control consisted of larvae inoculated with C. albicans
and no test solution administered. The latter control is the one
given in the results illustrated in Fig. 12. Significance was deter-
mined using the log rank (Mantel–Cox) method. Positive
results were placed into one of three categories: * = p < 0.05,
** = p < 0.01 and *** = p < 0.001.
Prophylactic treatment. The test solution (20 μl) was adminis-
tered to the larvae by injection as outlined above. Larvae were
then placed in sterile petri dishes and incubated at 303 K for 1 h,
after which time they were inoculated with 20 μl of the C. albi-
cans cell suspension (2 × 106 cells). This number represents a
lethal dose of fungal cells. The larvae were incubated at 303 K
for 72 h and larvae survival was monitored immediately after
this period.
Treatment of infection. Larvae were inoculated with 20 μl of
the C. albicans suspension (2 × 106 cells) by injection as
described above. The larvae were then placed in sterile petri
dishes and incubated at 303 K for 1 h, after which time the test
solution (20 μl) was administered by injection. The larvae were
incubated at 303 K for 72 h and larvae survival was monitored
immediately after this period.
Results and discussion
Complex syntheses and structures
Synthetic routes to the complexes are given in Scheme 1. Our
previously reported synthesis of [Ag2(9-aca)2] (1), from Ag2O
and 9-acaH,35 had the major drawback of a low product yield
(21%). A greatly improved yield (73%) was achieved by reacting
the salt, K+(9-aca)−, with AgNO3. The complex consists of poly-
meric ribbons of linked disilver(I), syn–syn bridged, dicarboxy-
late units and having an Ag–Ag distance of 2.851(1) Å.35
Complex 1 was used as the starting material for the preparation
of the other silver(I) complexes. The previously reported
complex, [Ag4(9-aca)4(NH3)2] (2),
35 was prepared by reacting 1
with aqueous ammonia. Complex 2 was shown to be tetrameric
and centrosymmetric, with two syn–syn bridging carboxylates
linked to the bimetallic Ag–Ag core, and a further two, syn–anti
bridged carboxylate ligands in the equatorial plane, being coor-
dinated to one Ag in the bimetallic core and to a second Ag,
with the latter also bonded to an NH3 ligand. The closest Ag–Ag
distance in the complex is 2.939(1) Å.
The imidazole complex, [Ag(imidH)2.3(CH3CN)0.7](9-aca)
(3), was synthesised from 1 and imidazole in acetonitrile. In this
process, 1 disintegrates and re-assembles as a mononuclear
complex where the metal ion is ligated by imidazole and aceto-
nitrile, and the 9-aca− ligands are relegated to uncoordinated
counterions. The X-ray crystal structure of 3 is shown in Fig. 2
and selected bond lengths and angles are given in Table 2. The
Ag(I) ion forms short bonds to the imine N atom of two imida-
zole molcules (both Ag–N = 2.126(2) Å). These Ag–N bonds
are slightly longer than those found in the mononuclear imida-
zole complexes, [Ag(imidH)2]NO3 (2.115(2) and 2.120(2) Å)
and [Ag(imidH)2]ClO4 (2.131(2) Å),
51 and also in the trisilver(I)
complex, [Ag3(imidH)6](ClO4)3 (2.075 Å).
52 A third ligand is
coordinated to the metal in 3 and this has been modelled as a
70 : 30 disorder between acetonitrile and imidazole, respectively.
The metal–nitrogen bonds to this third ligand are somewhat
longer again (Ag1–N51 acetonitrile = 2.713(8) Å; Ag1–N41
imidazole = 2.588(17) Å). There is also a longer interaction with
the carboxylate oxygen atom of a neighbouring 9-aca− unit
(Ag1–O2B = 3.009(2) Å) (Fig. 3). In [Ag(imidH)2.3(CH3CN)0.7]-
Scheme 1 Synthetic routes to the complexes.
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(9-aca) (3), the metal is coordinated approximately linearly with
the first two imidazole ligands (N21–Ag1–N31 = 168.51(10)°),
whilst the third ligand lies almost perpendicular (N21–Ag1–N51
= 93.7(3)°). The structure is linked into chains by hydrogen
bonding between carboxylate oxygens and the hydrogen atoms
on the pyrrole-type nitrogens (N–H) of the imidazoles (Fig. 3).
Table 2 Selected bond lengths (Å) and angles (°)
Complex 3 N21–Ag1–N31 168.51(10)
Ag1–N21 2.126(2) N21–Ag1–N41 96.1(6)
Ag1–N31 2.126(2) N31–Ag1–N41 94.7(6)
Ag1–N41 2.588(17) N21–Ag1–N51 93.7(3)
Ag1–N51 2.713(8) N31–Ag1–N51 96.0(3)
Ag1–O2* 3.009(2) N21–Ag1–O2* 93.98(8)
N31–Ag1–O2* 92.38(7)
N41–Ag1–O2* 76.5(3)
N51–Ag1–O2* 88.78(18)
Symmetry transformations used to generate equivalent atoms:
* −x + 1/2,y − 1/2,−z + 1/2
Complex 4
Ag1–N21 2.088(2) N21–Ag1–N31 174.33(10)
Ag1–N31 2.089(2) O(B–Ag2–O1A) 143.97(7)
Ag1–Ag2 3.0651(4) O1B–Ag2–O2A 154.09(7)
Ag2–O1B 2.218(2) O1A–Ag2–O2A 54.34(7)
Ag2–O1A 2.416(2) O1D–Ag3–O1C 162.45(8)
Ag2–O2A 2.424(2) O1D–Ag3–O41 102.11(7)
Ag3–O1D 2.1574(19) O1C–Ag3–O41 92.58(8)
Ag3–O1C 2.1681(19) O1D–Ag3–O2B 94.62(7)
Ag3–O41 2.467(2) O1C–Ag3–O2B 95.22(7)
Ag3–Ag3 2.8818(5) O41–Ag3–O2B 88.95(7)
Symmetry transformations used to generate equivalent atoms:
* −x,y,−z + 1/2
Complex 5
Ag1–O12C* 2.246(5) O12C*1–Ag1–O11C 156.3(2)
Ag1–O11C 2.272(5) O12C*–Ag1–O11A 100.7(2)
Ag1–O11A 2.316(6) O11C–Ag1–O11A 103.0(2)
Ag1–O11B 2.384(5) O12C*–Ag1–O11B 93.4(2)
Ag1–Ag1* 2.7860(12) O11C–Ag1–O11B 87.79(19)
Ag1–Ag2* 2.9623(9) O11A–Ag1–O11B 88.2(2)
Ag1–Ag2 3.0079(9) O12B*–Ag2–O12A 140.4(2)
Ag2–O12B* 2.188(5) O11E–Ag3–O12E† 158.7(2)
Ag2–O12A 2.193(5) O11E–Ag3–O11F 99.5(2)
Ag2–Ag1* 2.9623(9) O12E†–Ag3–O11F 101.7(2)
Ag3–O11E 2.222(6) O11E–Ag3–O11D 94.7(2
Ag3–O12E† 2.248(6) O12E†–Ag3–O11D 88.4(2)
Ag3–O11F 2.319(6) O11F–Ag3–O11D 86.8(2)
Ag3–O11D 2.389(5) O12D†–Ag4–O12F 140.9(2)
Ag3–Ag3† 2.7889(12) N1B–Ag5–N1A 170.8(3)
Ag3–Ag4† 2.9489(9) N1B–Ag5–O11B 90.4(2)
Ag3–Ag4 2.9838(9) N1A–Ag5–O11B 96.1(2)
Ag4–O12D† 2.183(5) N1B–Ag5–O11A 100.9(3)
Ag4–O12F 2.185(5) N1A–Ag5–O11A 87.1(3)
Ag4–Ag3† 2.9488(9) O11B–Ag5–O11A 75.53(17)
Ag5–N1B 2.124(9) N1C–Ag6–N1D 171.2(3)
Ag5–N1A 2.136(8) N1C–Ag6–O11D 91.8(2)
Ag6–N1C 2.131(8) N1D–Ag6–O11D 95.4(2)
Ag6–N1D 2.134(8) N1C–Ag6–O11F 84.1(3)
N1D–Ag6–O11F 102.8(3)
O11D–Ag6–O11F 73.58(17)
Symmetry transformations used to generate equivalent atoms:
* −x + 1,−y,−z † −x + 2,−y,−z + 1
Complex 6
Ag1–O1A 2.207(4) O1A–Ag1–O2D 132.81(16)
Ag1–O2D 2.217(4) O1E–Ag2–O1F 154.83(15)
Ag1–Ag4 2.8750(6) O1E–Ag2–O2A 108.55(15)
Ag1–Ag2 2.9028(6) O1F–Ag2–O2A 91.25(14)
Ag2–O1E 2.222(4) O1E–Ag2–O1B 94.95(15)
Ag2–O1F 2.226(4) O1F–Ag2–O1B 99.15(16)
Ag2–O2A 2.335(4) O2A–Ag2–O1B 93.86(14)
Ag2–O1B 2.357(4) O1C–Ag3–O2B 135.29(16)
Ag2–Ag4 2.8365(5) O1D–Ag4–O2C 89.46(15)
Ag2–Ag3 2.8770(6) O1D–Ag4–O2F 107.09(18)
Ag3–O1C 2.174(4) O2C–Ag4–O2F 93.00(15)
Ag3–O2B 2.192(4) O1D–Ag4–O2E 92.01(17)
Ag3–Ag4 2.8949(6) O2C–Ag4–O2E 102.37(15)
Ag4–O1D 2.275(4) O2F–Ag4–O2E 155.64(13)
Ag4–O2C 2.304(4) N1A–Ag5–N1B 176.98(18)
Ag4–O2F 2.354(4) N1A–Ag5–O2A 93.44(16)
Ag4–O2E 2.355(4) N1B–Ag5–O2A 89.43(15)
Ag5–N1A 2.116(5) N1A–Ag5–O1B 89.53(16)
Table 2 (Contd.)
Ag5–N1B 2.117(5) N1B–Ag5–O1B 92.03(16)
Ag6–N1D 2.131(5) O2A–Ag5–O1B 76.98(11)
Ag6–N1C 2.131(5) N1D–Ag6–N1C 175.1(2)
N1D–Ag6–O1D 90.55(19)
N1C–Ag6–O1D 94.19(19)
N1D–Ag6–O2C 97.24(17)
N1C–Ag6–O2C 85.17(16)
O1D–Ag6–O2C 73.86(12)
Ag7–O1G 2.196(4) O1G–Ag7–O2J 132.37(16)
Ag7–O2J 2.202(4) O2J–Ag7–O1L 105.68(16)
Ag7–O1L 2.564(4) O1K–Ag8–O2L 153.12(15)
Ag7–Ag10 2.8760(6) O1K–Ag8–O2G 99.71(16)
Ag7–Ag8 2.9646(6) O2L–Ag8–O2G 104.46(16)
Ag8–O1K 2.217(4) O1K–Ag8–O1H 104.54(16)
Ag8–O2L 2.257(4) O2L–Ag8–O1H 85.64(14)
Ag8–O2G 2.301(4) O2G–Ag8–O1H 93.64(14)
Ag8–O1H 2.382(4) O1I–Ag9–O2H 135.17(16)
Ag8–Ag10 2.8165(5) O2I–Ag10–O1J 88.66(15)
Ag8–Ag9 2.8544(6) O2I–Ag10–O2K 95.31(16)
Ag9–O1I 2.178(4) O1J–Ag10–O2K 109.95(17)
Ag9–O2H 2.203(4) O2I–Ag10–O1L 99.16(15)
Ag9–Ag10 2.9511(6) O1J–Ag10–O1L 87.68(16)
Ag10–O2I 2.286(4) O2K–Ag10–O1L 157.45(14)
Ag10–O1J 2.304(4) N1E–Ag11–N1F 176.84(19)
Ag10–O2K 2.309(4) N1E–Ag11–O1H 93.65(16)
Ag10–O1L 2.374(4) N1F–Ag11–O1H 89.24(16)
Ag11–N1E 2.112(5) N1E–Ag11–O2G 87.63(17)
Ag11–N1F 2.113(5) N1F–Ag11–O2G 94.29(16)
Ag12–N1H 2.122(5) O1H–Ag11–O2G 76.30(11)
Ag12–N1G 2.124(5) N1H–Ag12–N1G 175.0(2)
N1H–Ag12–O1J 94.68(18)
N1G–Ag12–O1J 90.14(18)
N1H–Ag12–O2I 86.61(17)
N1G–Ag12–O2I 95.99(18)
O1J–Ag12–O2I 73.43(12)
Complex 7
Ag1–N1 2.0841(18)
Ag1–N3* 2.1069(18) N1–Ag1–N3* 177.76(7)
Symmetry transformations used to generate equivalent atoms:
* −x + 1/2, y + 1/2, z
Fig. 2 The asymmetric unit of [Ag(imidH)2.3(CH3CN)0.7](9-aca) (3)
showing the disorder of one imidH with CH3CN.
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 6516–6527 | 6521
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This assembly is further supported by π–π stacking of the imida-
zole groups, with a centroid–centroid distance of 3.64 Å.
The IR spectrum of 3 exhibits a weak band at 2250 cm−1 for
the CuN bond stretching vibration. Bands are also observed at
3436 and 1072 cm−1, corresponding to the N–H and C–N
stretching vibrations of imidazole, respectively.51 Bands for the
anthracene ring system occur at 1625, 760 and 739 cm−1.53,54
Carboxylate ν(OCO)asym and ν(OCO)sym vibrations are present at
1562 and 1426 cm−1, respectively, giving a Δ(OCO) value of
136 cm−1. This value indicates a bridging carboxylate which, in
this case, is associated with the pseudo-bridging via hydrogen
bonds.55
[Ag6(imidH)4(9-aca)6(MeOH)2] (4) was synthesised from 1
and imidazole in methanol, with a yield of 44%. Thus, a minor
change in the reaction conditions (methanol as solvent as
opposed to acetonitrile) causes a dramatic change in the product
formulation. The X-ray crystal structure of the hexanuclear
complex 4 (Fig. 4 and Table 2) shows that there is a two-fold
axis through the molecule and that it contains both three- and
five-coordinate silver(I) ions (Fig. 5). The Ag1–Ag2 bond length
is 3.0651(4) Å, while the Ag3–Ag3A bond is significantly
shorter at 2.8818(5) Å. Both of these Ag–Ag distances are close
to that in metallic silver (2.889(6) Å) and are much shorter than
the sum of the van der Waals radii of two Ag(0) atoms (3.44 Å),
implying the existence of d10–d10 interactions between two
closed-shell Ag(I) ions. Such argentophilic interactions have
been observed in a large number of multinuclear Ag(I) com-
plexes.56 In 4, Ag1 is coordinated approximately linearly by two
imidazoles (N21–Ag1–N31 bond angle of 174.33(10)°) with
identical Ag–N bond lengths (2.088(2) Å). These latter bonds
are slightly shorter than the corresponding Ag–N bond (2.126(2)
Å) of the ordered imidazole in [Ag(imidH)2.3(CH3CN)0.7](9-aca)
(3). In complex (4), Ag2 is coordinated to three different carbox-
ylate groups as well as being bonded to Ag1. Ag3 is also coordi-
nated to three different carboxylate groups, plus the oxygen of a
coordinated methanol molecule and another silver ion (Ag3A).
Fig. 3 Weak interactions of the silver(I) centre with the carboxylate
oxygen atoms and the H-bonding between the imidazole N–H and car-
boxylate oxygens in [Ag(imidH)2.3(CH3CN)0.7](9-aca) (3). The disor-
dered solvate ligand has been omitted for clarity and H-bonds are
represented by dashed lines.
Fig. 5 Coordination sphere of [Ag6(imidH)4(9-aca)6(MeOH)2] (4) with
the imidazole and anthracene rings omitted for clarity.
Table 3 Antimicrobial activities of complexes 1–7, silver nitrate and the clinically used compounds, ketoconazole and silver sulfadiazine. MIC
values are given in μM concentrations of complex and Ag(I) ions (in brackets)
Complex
E. coli MIC50 (μM)
{[Ag+] μM}
MRSA MIC50 (μM)
{[Ag+] μM}
C. albicans MIC100 (μM)
{[Ag+] μM}
[Ag2(9-aca)2] (1) 22.44 {44.88} 11.36 {22.72} 0.95 {1.90}
[Ag4(9-aca)4(NH3)2] (2) 8.51 {34.04} 5.44 {21.76} 0.14 {0.56}
[Ag(imidH)2.3(CH3CN)0.7](9-aca) (3) 20.66 {20.66} 67.07 {67.07} 0.38 (0.38}
[Ag6(imidH)4(9-aca)6(MeOH)2] (4) 1.87 {11.22} 5.85 {35.10} 0.54 {3.24}
{[Ag(1-Me-imid)2]2[Ag4(9-aca)6]} (5) 8.64 {51.84} 8.10 {48.60} 0.34 {2.04}
{[Ag(1-Bu-imid)2]2[Ag4(9-aca)6]} (6) 7.04 {42.24} 6.16 {36.96} 0.32 {1.92}
[Ag(apim)](9-aca)·H2O (7) 30.13 {30.13} 27.50 {27.50} 0.43 {0.43}
AgNO3 65.19 {65.19} 34.32 {34.32} 1.83 {1.83}
Ketoconazole 4.70
Silver sulfadiazine 73.05 {73.05} 50.20 {50.20}
Fig. 4 Structure of [Ag6(imidH)4(9-aca)6(MeOH)2] (4). The two-fold
axis lies in the plane of the page and bisects the Ag3–Ag3Avector (sym-
metry code −x,y,−z + 1/2). H-bonds are represented by dashed lines.
6522 | Dalton Trans., 2012, 41, 6516–6527 This journal is © The Royal Society of Chemistry 2012
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Two of the carboxylate ligands are in the syn–syn configuration
(O1C and O1Ca, O1D and O1DA), two are syn–anti (O1B and
O2B, O1BA and O2BA) and two are coordinated in a symmetri-
cal, bidentate chelation mode (O1A and O2A, O1AA and
O2AA). There is also intramolecular H-bonding between the OH
of the alcohol group and a neighbouring carboxylate oxygen
atom (O41–O1A 2.782(3) Å), as well as intermolecular H-
bonding between the amine hydrogen of the imidazole and a car-
boxylate oxygen of a neighbouring 9-aca− ligand (N22–O2A
2.796(3) Å under symmetry operation −x + 1/2, y − 1/2, z and
N32–O2B, 2.815(3) under −x + 1/2, y + 1/2, z). A very weak
π-interaction between Ag(1) and the anthracene ring of a neigh-
bouring molecule is also observed. The structure of 4 is quite
different to that of the recently reported, hexanuclear, centrosym-
metric complex, [Ag6(dmp)2(9-aca)6] (dmp = 2,6-dimethylpyri-
dine),57 prepared by reacting AgNO3 with 9-acaH in the
presence of dmp. In this complex, all six Ag(I) ions are ligated
by carboxylate oxygen atoms, and the two heterocyclic, N-donor
dmp ligands are bonded to separate metal centres. In addition,
the solid state structure of [Ag6(dmp)2(9-aca)6] exhibits intramo-
lecular and intermolecular anthracene C–H⋯Ag interactions as
well as π–π stacking interactions. The metal coordination geome-
try within the hexanuclear core of 4 is also very different to that
recently reported for a number of hexa-Ag(I) thiosemicarbazone
complexes and, furthermore, the shortest Ag–Ag distances in the
latter complexes are significantly longer than in 4.57–59
The IR spectrum of 4 has peaks at 3448 and 1091 cm−1 for
the O–H and C–N stretching vibrations of MeOH and imidazole,
respectively. Distinctive bands for the vibrations of the anthra-
cene ring system appear at 1625, 760 and 736 cm−1. Carboxylate
ν(OCO)asym and ν(OCO)sym vibrations occur at 1538 and
1433 cm−1, respectively, giving a Δ(OCO) value of 105 cm
−1 and
implying the presence of bridging carboxylates.
The initial beige precipitate which formed upon reacting 1
with 1-methylimidazole (1-Me-imidH) in ethanol was recrystal-
lised from DMSO to give {[Ag(1-Me-imid)2]2[Ag4(9-aca)6]}
(5). The X-ray crystal structure of 5 (Fig. 6 and Table 2) shows it
to consist of two independent, centrosymmetric molecules which
differ chiefly in the angle between the planes of the anthracene
ligands. Each molecule of 5 contains a dianionic, complex
central core, [Ag4(9-aca)6]
2−, with the two complex cations,
[Ag(1-Me-imidH)2]
+, on the periphery of the molecule. It is the
manner in which these two dications are each linked to the tetra-
nuclear core by a bridging carboxylate oxygen atom that princi-
pally distinguishes this structure from 4.
The central tetrasilver(I) cluster in 5 contains Ag–Ag bond
lengths ranging from 2.786 to 3.009 Å, and the average distance
from a core metal to a peripheral metal is 5.821 Å (Fig. 7). The
Ag1–Ag1A distance of 2.786 Å in 5 is the shortest in the present
family of Ag(I) anthracenecarboxylate complexes and it is also
significantly smaller than any argentophilic interactions found in
[Ag6(dmp)2(9-aca)6] (minimum Ag–Ag is 2.895 Å).
57 In
complex 5, two 9-aca− ligands (O11C, O12C and O11I, O12I)
are coordinated in a syn–syn fashion to the central silver(I) ions
(Ag1, Ag1A), and the other four carboxylate ligands are
Fig. 6 The two independent molecules of [Ag(1-Me-imid)2]2[Ag4(9-
aca)6] (5) illustrating the difference in arrangement of the anthracene
ligands.
Fig. 7 Simplified structures of [Ag(1-Me-imid)2]2[Ag4(9-aca)6] (5)
showing (a) Ag–Ag and Ag–O bonding and (b) Ag–Ag bond distances
(Å) for one of the molecules.
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 6516–6527 | 6523
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coordinated to two central silver(I) ions and one peripheral silver
(I) ion. The average core Ag–O bond length is 2.304 Å (e.g.
Ag1–O11) and the average peripheral Ag–O bond length is
2.671 Å (e.g. (Ag5–O11A). The 1-Me-imid ligands are coordi-
nated to the metals through the imine N atom and lie in an
approximately linear arrangement (N1A–Ag5–N1B bond angle
is 171.10°). The methyl groups on each of the two imidazole
ligands are cis to each other and are orientated towards the centre
of the molecule.
The IR spectrum of 5 contains bands at 1621, 772 and
736 cm−1 for the anthracene ring system, and a band for the
C–N stretching vibration of the imidazole ring at 1087 cm−1.
The carboxylate ν(OCO)asym and ν(OCO)sym stretching vibrations
occur at 1565 and 1428 cm−1, respectively, giving a Δ(OCO)
value of 137 cm−1. This value indicates the presence of carboxy-
lates with a chelating and/or bridging mode of coordination.
The reaction of 1 with 1-butylimidazole in acetonitrile pro-
duced a beige solid which, upon recrystallisation from ethanol,
yielded {[Ag(1-Bu-imid)2]2[Ag4(9-aca)6]} (6). The X-ray crystal
structure of 6 (Fig. 8, Table 2) shows two very similar but inde-
pendent assemblies within the asymmetric unit and orientated at
approximately 90° to each other. There is also some disorder
within the butyl chains of the imidazole ligands. The complex
contains two-, four- and six-coordinate silver(I) ions (Fig. 9).
Two of the metals are coordinated approximately linearly to the
imine nitrogen atoms of two 1-Bu-imid ligands (bond angles of
176.98(18), 175.1(2), 176.84(19) and 175.0(2)°), with an
average Ag–N bond length of 2.124 Å. There are also longer
Fig. 8 X-ray crystal structure of [Ag(1-Bu-imid)2]2[Ag4(9-aca)6] (6) showing the two independent assemblies.
Fig. 9 Structure of one molecule of {[Ag(1-Bu-imid)2]2[Ag4(9-aca)6]} (6) with the anthracene rings and alkyl chains removed for clarity.
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interactions of these silver ions with carboxylate oxygen atoms
at the central core of the molecule (Ag5–O2A, Ag5–O1B,
Ag6–O2C and Ag6–O1D bond lengths of 2.696(4), 2.809(4),
2.756(4) and 2.603(4) Å, respectively). Within the central,
dicationic [Ag4(9-aca)6]
2− core there are five Ag–Ag bonds, with
lengths ranging from 2.8165(5) to 2.9646(6) Å. All of the
anthracene ligands use both of their carboxylate oxygen atoms to
coordinate to two different silver ions in a syn–syn binding
mode. There are no intramolecular or intermolecular π–π inter-
actions between either the anthracene or the imidazole rings. The
structure of 6 is very similar to that of 5, indicating that the
change in the length of the alkyl chain (from methyl to butyl) on
the tertiary N atom of the imidazole ring does not appear to
affect the core structure of the product.
The IR spectrum of 6 contains bands for the anthracene rings
at 1622, 759 and 732 cm−1. The band representing the C–N
stretching vibration of the 1-Bu-imid ligands occur at
1085 cm−1. Carboxylate ν(OCO)asym and ν(OCO)sym vibrations
appear at 1565 and 1427 cm−1, respectively, giving a Δ(OCO)
value of 138 cm−1 and indicating that the carboxylate ligands
are coordinated in either a chelating or a bridging mode.
[Ag(apim)](9-aca)·H2O (7) was synthesised in high yield from
1 and 1-(3-aminopropyl)-imidazole (apim) in acetonitrile. The
X-ray crystal structure of 7 (Fig. 10, Table 2) shows the metal
bonded to the imine nitrogen atom of the imidazole ring (Ag1–
N1 = 2.0841(18) Å). The metals and the apim ligands bond
together to form 1-D, zig-zag polymeric chains (Fig. 11) with
the silver being coordinated approximately linearly to the imine
nitrogen of one apim and the nitrogen of the pendant amine
function of another imidazole (Ag1–N3A = 2.1069(18) Å and
N1–Ag1–N3A = 177.76(7)°). π–π Stacking interactions are also
observed between the imidazole rings, creating 2-D sheets (ESI†
Fig. a). The water molecule of hydration links to the anionic
9-aca− units through H-bonds forming polymeric chains which
zig-zag in-and-out through the spaces in the [Ag(apim)]n
n+
sheets (ESI† Fig. b). There are also H-bonding interactions
linking a carboxylate oxygen to the hydrogen of the pendant
amine group (ESI† Fig. c). Due to the relatively long distance
between the sheets, there are no π–π interactions involving the
anthracene rings. The structurally similar and previously charac-
terised60 apim complex, [Ag(apim)]ClO4, also shows the same
type of zig-zag arrangement of polymeric [Ag(apim)]n
n+ chains,
but this complex has weak metal–anion (ClO4
−) interactions
which are not present in 7.
The IR spectrum of 7 contains bands at 3427 and 3236 cm−1
corresponding to the apim NH2 stretching vibrations, and a band
at 1089 cm−1 for the C–N stretching vibration of the imidazole
ring. Two bands are present at 761 and 735 cm−1 for the stretch-
ing vibrations of the anthracene ring system, but the third band,
which is usually located at approximately 1625 cm−1, is masked
by the strong ν(OCO)asym carboxylate stretching band centred at
1568 cm−1. The ν(OCO)sym stretching vibration occurs at
1426 cm−1, thus giving a Δ(OCO) value of 142 cm
−1. Although
this value implies that the carboxylate is either chelating or brid-
ging55 it is evident from the X-ray crystal structure of the
complex that this is not the case. Thus, it must be stressed that
coordination mode assignments based on Δ(OCO) values
55 can,
indeed, be quite tentative.
In summary, it is evident from the formulations of complexes
3–7 that a slight change in either the reaction solvent or the
structure of the imidazole ligand employed during the synthesis
can have a marked effect on the structure of the isolated product.
Unsubstituted imidazole leads to the mononuclear species, 3.
Having an alkyl substituent on the tertiary N atom of the imida-
zole gives the hexanuclear complexes, 4, 5 and 6. When the
alkyl substituent carries an amine functionality on its terminus
the polymeric complex 7 forms.
Antimicrobial activity
The silver(I) complexes, 1–7, the simple silver(I) salt, silver
nitrate, and selected, known antimicrobial drugs (antibacterial
silver sulfadiazine and antifungal ketoconazole) were screened,
in vitro, for their ability to inhibit the growth of pathogenic bac-
terial and fungal cells. Activities (as MIC50 or MIC100 values)
are reported (Table 3) as μM concentrations of the complexes
and also as μM concentrations of administered Ag(I) ion in con-
sideration of the different amounts of Ag(I) ions present in the
various complexes. Test solutions (or suspensions) were made
by dissolving the sample in DMSO and diluting with water to
yield the required concentration. The maximum DMSO concen-
tration in any test solution was 0.5% v/v, and at this level the
DMSO does not inhibit the growth of the microbial cells. The
metal-free ligands (9-acaH and the various imidazoles) were also
screened for their biological activity and all were inactive at a
concentration of ≤100 μg cm−3.
In terms of both complex concentration and the concentration
of Ag(I) ions, 1–7 were all more active than AgNO3 and silver
sulfadiazine against Gram-negative E. coli. Against Gram-posi-
tive MRSA, only 3 was less active, in terms of complex concen-
tration, than AgNO3. Comparisons made on the basis of Ag(I)
ion concentration reveal that only complexes 1, 2 and 7 were
Fig. 10 Structure of one asymmetric unit of [Ag(apim)](9-aca)·H2O
(7).
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more active against MRSA than AgNO3. In terms of Ag(I) ion
concentration, 1, 2 and 7 were more active than AgNO3 against
both species of bacteria. The structurally similar double complex
salts, 5 and 6, displayed similar antibacterial properties.
With respect to complex concentrations, 1–7 were all con-
siderably more active against C. albicans than both ketoconazole
and AgNO3 (Table 3). However, as a function of Ag(I) ion con-
centration, only 2, 3 and 7 were a lot more active than AgNO3.
The latter three complexes, which all contain N-donor imidazole
ligands, were more active than the parent carboxylate complex,
1. Complexes 5 and 6, which contain imidazole ligands carrying
substituents (Me or Bu) on the N1 atom of the heterocyclic ring,
and which also have ligated 9-aca− anions, appear to be only
marginally more active than hexanuclear 4, which has un-substi-
tuted imidazoles coordinated to two of the metal centres. Against
all three microbial species, and in terms of Ag(I) ion content,
only 2 and 7 were significantly more active than AgNO3.
In vivo toxicity profiling was carried out using the G. mello-
nella insect model. G. mellonella larvae were administered with
test solutions (or suspensions) by injection directly into the hae-
mocoel through the last pro-leg. Survival was monitored after
72 h and death was assessed by the lack of movement in
response to stimulus together with discoloration of the cuticle.
The toxicity of all of the test samples was assessed at two differ-
ent concentrations: 100 μg cm−3 and twice their MIC100 value.
Silver nitrate and ketoconazole were used as reference standards.
It was found that all of the larvae survived the highest adminis-
tered concentration (100 μg cm−3) of AgNO3, ketoconazole and
complexes 1–7. Two types of in vivo antifungal screening proto-
cols were conducted using the larvae: (i) prophylactic treatment
and (ii) the treatment of infection (pre-infected larvae). The
larvae were infected with a lethal dose of C. albicans (2 × 106
fungal cells) in each of the two screening protocols. For prophy-
lactic treatment, the test compound was administered 1 h prior to
infection with C. albicans cells, while for the treatment of infec-
tion experiments the compound was administered 1 h after infec-
tion with C. albicans. In each case, larvae survival was assessed
after a 72 h interval and the results are presented in Fig. 12.
Complex 2, administered prophylactically at a concentration
of 100 μg cm−3, significantly increased the survival rate (90%)
of G. mellonella larvae 72 h after infection with a lethal dose of
C. albicans cells. This response was superior to that given by
AgNO3 (80%) and ketoconazole (75%), which were, in turn,
better than that the other Ag(I) complexes. When the prophylac-
tic experiment was repeated using a concentration dosage of
2 × MIC100 concentration the % survival of larvae decreased
in all cases. Complex 2 still offered the best protection (65%
survival) and this was followed by AgNO3 (55%). Complex 1
and ketoconazole were equally active (50%) at this dosage.
Larvae which were pre-infected with a lethal dose of C. albi-
cans cells and then subsequently treated with 100 μg cm−3 of
the test compounds, responded best to ketoconazole and silver
nitrate (both gave 75% survival after 72 h). The most effective
Ag(I) complex was 7 (70%), followed by 5 (60%) and 2 (60%).
At the 2 × MIC100 concentration dosage all of the test materials
Fig. 11 [Ag(apim)]n
n+ cationic polymer chains in the structure of [Ag(apim)](9-aca)·H2O (7).
Fig. 12 Survival of G. mellonella larvae 72 h after being infected with
a lethal dose of C. albicans (2 × 106 fungal cells). For prophylactic treat-
ment, the test compound was administered 1 h prior to infection with C.
albicans cells, while for the treatment of infection experiments the com-
pound was administered 1 h after infection with C. albicans. Com-
pounds tested were AgNO3, ketoconazole and 1–7. All compounds were
administered at two different concentrations (100 μg cm−3 and 2 ×
MIC100 concentration in μg cm
−3).
6526 | Dalton Trans., 2012, 41, 6516–6527 This journal is © The Royal Society of Chemistry 2012
D
ow
nl
oa
de
d 
by
 N
U
I M
ay
no
ot
h 
on
 2
9 
Ja
nu
ar
y 
20
13
Pu
bl
ish
ed
 o
n 
05
 A
pr
il 
20
12
 o
n 
ht
tp
://
pu
bs
.rs
c.o
rg
 | d
oi:
10.
103
9/C
2D
T1
216
6B
View Article Online
generally offered less protection towards a pre-existing fungal
infection than at the 100 μg cm−3 concentration level. AgNO3
performed best (60% survival), followed by 1 (35%), 2 (30%)
and 5 (30%). Under the same conditions, only 20% of infected
larvae survived upon treatment with ketoconazole.
In summary, the prophylactic method of administering the
silver(I) complexes proved more effective at increasing the survi-
val rate of G. mellonella infected with C. albicans. This may be
attributed not only to the efficacy of the test compound (direct
anti-effect) but also to the anticipated increase in the number of
haemocytes, antimicrobial peptides and proteins produced by the
innate immune system of the insect in response to the presence
of the administered foreign substance (indirect anti-effect).50
Conclusions
A myriad of structurally diverse Ag(I) complexes containing the
9-anthracenecarboxylate anion and imidazoles can be syn-
thesised from the parent complex, [Ag2(9-aca)2] (1). While
many of the complexes possess excellent, in vitro antifungal and
antibacterial activities they are, unanimously, more effective
against fungal cells. G. mellonella can survive high doses of the
Ag(I) complexes administered in vivo, and a number of the com-
plexes offer significant protection to larvae infected with a lethal
dose of pathogenic C. albicans cells. These silver complexes
offer significant potential as new antimicrobial agents for clinical
application.
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